The S&P/ASX 200 Index (ASX: XJO) has continued its positive form on Thursday. In afternoon trade, the benchmark index is up 0.6% to 7,158.5 points.
Four ASX shares that are climbing more than most today are listed below. Hereâs why they are rising:
Argosy Minerals Limited (ASX: AGY)
The Argosy Minerals share price is up 4% to 58.2 cents. Investors have been buying this lithium developerâs shares after it provided an update on the Rincon Lithium Project in Argentina. According to the release, current commissioning works have produced a battery quality 99.76% lithium carbonate product. This was achieved during part of the overall development towards commencing the 2,000tpa lithium carbonate operation.
Arafura Rare Earths Ltd (ASX: ARU)
The Arafura share price 4.5% to 46 cents. This may have been driven by bargain hunters swooping in after recent share price weakness. Prior to today, the rare earths developerâs shares were down approximately 17% in the space of a week.
Deep Yellow Limited (ASX: DYL)
The Deep Yellow share price is up 7% to 74 cents. This uranium developerâs shares were already racing higher prior to the release of a positive announcement this afternoon. That announcement reveals that it has completed its two-stage, 10,000m follow-up reverse circulation drill program at the Omahola project, with positive results delivered and new targets identified.
Pro Medicus Limited (ASX: PME)
The Pro Medicus share price is up 5% to $57.17. Investors have been buying this health imaging technology companyâs shares after it signed a $15 million seven-year deal with Luminis Health. Pro Medicusâ technology will replace legacy PACS throughout the Luminis Health network. Management also revealed that its pipeline remains strong and spans all market segments.
The post Why Argosy Minerals, Arafura, Deep Yellow, and Pro Medicus shares are charging higher appeared first on The Motley Fool Australia.
FREE Guide for New Investors
Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…
For over a decade, we’ve been helping everyday Aussies get started on their journey.
And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.
Yes, Claim my FREE copy!
*Returns as of November 7 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Why did the Arafura Rare Earths share price dive 9% on Tuesday?
- Why Appen, Arafura, Aurizon, and Star shares are sinking today
- Why is the Arafura Rare Earths share price rocketing 13% today?
- Why Arafura, Block, Leo Lithium, and St Barbara shares are storming higher
- Why Arafura, Megaport, Nitro, and Sayona Mining shares are storming higher today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/WLcuyVl
Leave a Reply